JenaValve Raises $62.5 Million To Fund Transfemoral TAVI Trial And More
This article was originally published in The Gray Sheet
Executive Summary
Funds will help the German company continue developing its JenaValve transcatheter aortic valve, including a new clinical trial of the transfemoral version of the system.